| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.46M | 7.68M | 6.70M | 9.69M | 7.31M | 10.53M |
| Gross Profit | 6.75M | 7.14M | 6.06M | 8.99M | 6.65M | 9.47M |
| EBITDA | -9.28M | -14.39M | -36.69M | -39.13M | -32.47M | -33.27M |
| Net Income | -17.52M | -13.51M | -36.48M | -29.61M | -37.59M | -34.33M |
Balance Sheet | ||||||
| Total Assets | 10.36M | 14.92M | 23.11M | 26.54M | 42.19M | 41.32M |
| Cash, Cash Equivalents and Short-Term Investments | 6.08M | 9.73M | 18.25M | 19.11M | 27.76M | 21.04M |
| Total Debt | 749.00K | 889.00K | 795.00K | 539.00K | 1.82M | 2.89M |
| Total Liabilities | 4.94M | 5.35M | 6.50M | 8.64M | 7.76M | 12.12M |
| Stockholders Equity | 5.42M | 9.57M | 16.61M | 16.56M | 34.42M | 29.19M |
Cash Flow | ||||||
| Free Cash Flow | -8.98M | -14.88M | -30.67M | -27.70M | -34.00M | -24.23M |
| Operating Cash Flow | -8.86M | -14.77M | -30.60M | -27.50M | -28.23M | -18.71M |
| Investing Cash Flow | -121.76K | -107.00K | -43.00K | -158.00K | -5.76M | -5.51M |
| Financing Cash Flow | 6.13M | 6.44M | 29.10M | 19.48M | 40.79M | 21.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £200.75M | 19.34 | 11.31% | 1.68% | 6.27% | 0.83% | |
70 Outperform | £96.55M | 13.31 | 5.30% | ― | -3.95% | 16.87% | |
68 Neutral | £121.09M | 32.89 | 12.39% | 0.79% | 12.10% | 27.35% | |
68 Neutral | £215.66M | 51.02 | 9.59% | 0.80% | 22.80% | -32.13% | |
68 Neutral | £199.32M | -996.43 | -2.20% | ― | 31.86% | -115.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £22.74M | -1.61 | -268.88% | ― | 1.65% | 29.02% |
Cirata plc has granted new equity-based awards under its Share Options Plan to Chief Technical Officer Paul Scott Murphy and Chief Revenue Officer Dominic Arcari, reflecting the board’s use of long-term incentives to align senior leadership with shareholder interests. Murphy received options over 600,000 ordinary shares, split between time-based options priced at 20.6 pence vesting quarterly to February 2029 and performance-based options at a 10 pence strike that vest in December 2027 only if the share price reaches at least 75 pence, taking his total option holding to 1.06% of the company’s share capital alongside a small direct shareholding. Arcari was awarded 300,000 performance-based options at a 10 pence strike subject to the same 75 pence share price hurdle by December 2027, lifting his option holding to 0.51% of outstanding shares and reinforcing performance-linked remuneration as Cirata seeks to motivate and retain key executives while tying their rewards to long-term share price appreciation.
The most recent analyst rating on (GB:CRTA) stock is a Sell with a £20.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.
Cirata reported a record finish to FY25, with Data Integration bookings surging 181% year-on-year to $13.2m and Q4 DI bookings hitting an all-time quarterly high of $9.8m, underpinned by the largest direct contract ($3.1m with a leading US insurer) and the largest OEM contract ($6.7m via IBM) in the company’s history. Following the strategic divestment of its renewal-heavy DevOps business for a total $3.4m, the group has refocused entirely on higher-growth Data Integration and Orchestration products, launched its Cirata Symphony platform, sharply reduced annualised cash overheads to about a third of their FY21 peak and cut annual cash burn to $5.7m, positioning management to target cash-flow breakeven in FY26 and signalling a leaner, expansion-led growth strategy geared toward existing blue-chip clients and new enterprise wins.
The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.
Cirata plc has received the final consideration payment of US$900,000 from BlueOptima following the completion of the divestment of its DevOps assets, confirming that no further sums are due under the transaction agreed earlier in 2025. The receipt of this final payment closes out the DevOps disposal process, providing full clarity on proceeds from the sale and allowing Cirata to move forward with its refocused operations without any remaining financial contingencies related to the transaction.
The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.
Cirata plc, a company in the UK tech sector, has announced that the Financial Conduct Authority (FCA) has closed its investigation into the company without taking any action. The investigation, which began in April 2023, focused on whether Cirata had mis-stated its financial position in regulatory announcements between May 2021 and March 2023. CEO Stephen Kelly highlighted the efforts of the new management team in restructuring the company and launching the Cirata Symphony Data Orchestration Platform, marking a new chapter for the company.
The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.
Cirata plc has secured a significant $6.7 million, three-year contract with IBM to provide data integration software for a financial services client. This contract, the largest in Cirata’s history with IBM, is expected to enhance Cirata’s standing in the financial services market and strengthen its strategic partnership with IBM.
The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.